These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 38360615)
1. Exosomes secreted by Fusobacterium nucleatum-infected colon cancer cells transmit resistance to oxaliplatin and 5-FU by delivering hsa_circ_0004085. Hui B; Zhou C; Xu Y; Wang R; Dong Y; Zhou Y; Ding J; Zhang X; Xu J; Gu Y J Nanobiotechnology; 2024 Feb; 22(1):62. PubMed ID: 38360615 [TBL] [Abstract][Full Text] [Related]
2. Exosome-Mediated Transfer of circ_0000338 Enhances 5-Fluorouracil Resistance in Colorectal Cancer through Regulating MicroRNA 217 (miR-217) and miR-485-3p. Zhao K; Cheng X; Ye Z; Li Y; Peng W; Wu Y; Xing C Mol Cell Biol; 2021 Apr; 41(5):. PubMed ID: 33722958 [TBL] [Abstract][Full Text] [Related]
3. Fusobacterium nucleatum promotes chemoresistance to 5-fluorouracil by upregulation of BIRC3 expression in colorectal cancer. Zhang S; Yang Y; Weng W; Guo B; Cai G; Ma Y; Cai S J Exp Clin Cancer Res; 2019 Jan; 38(1):14. PubMed ID: 30630498 [TBL] [Abstract][Full Text] [Related]
4. Exosome-Derived Circ_0094343 Promotes Chemosensitivity of Colorectal Cancer Cells by Regulating Glycolysis via the miR-766-5p/TRIM67 Axis. Li C; Li X Contrast Media Mol Imaging; 2022; 2022():2878557. PubMed ID: 35854778 [TBL] [Abstract][Full Text] [Related]
5. Serum exosomal hsa-circ-0004771 modulates the resistance of colorectal cancer to 5-fluorouracil via regulating miR-653/ZEB2 signaling pathway. Qiao XX; Shi HB; Xiao L Cancer Cell Int; 2023 Oct; 23(1):243. PubMed ID: 37845688 [TBL] [Abstract][Full Text] [Related]
6. Exosome-delivered circRNA promotes glycolysis to induce chemoresistance through the miR-122-PKM2 axis in colorectal cancer. Wang X; Zhang H; Yang H; Bai M; Ning T; Deng T; Liu R; Fan Q; Zhu K; Li J; Zhan Y; Ying G; Ba Y Mol Oncol; 2020 Mar; 14(3):539-555. PubMed ID: 31901148 [TBL] [Abstract][Full Text] [Related]
7. Exosomal transfer of circular RNA FBXW7 ameliorates the chemoresistance to oxaliplatin in colorectal cancer by sponging miR-18b-5p. Xu Y; Qiu A; Peng F; Tan X; Wang J; Gong X Neoplasma; 2021 Jan; 68(1):108-118. PubMed ID: 33147048 [TBL] [Abstract][Full Text] [Related]
8. Fusobacterium nucleatum induces oxaliplatin resistance by inhibiting ferroptosis through E-cadherin/β-catenin/GPX4 axis in colorectal cancer. Li B; Wei Z; Wang Z; Xu F; Yang J; Lin B; Chen Y; Wenren H; Wu L; Guo X; Liu Y; Wei Y Free Radic Biol Med; 2024 Aug; 220():125-138. PubMed ID: 38657754 [TBL] [Abstract][Full Text] [Related]
9. Circ_0007031 enhances tumor progression and promotes 5-fluorouracil resistance in colorectal cancer through regulating miR-133b/ABCC5 axis. He X; Ma J; Zhang M; Cui J; Yang H Cancer Biomark; 2020; 29(4):531-542. PubMed ID: 32865180 [TBL] [Abstract][Full Text] [Related]
10. Heterogeneous nuclear ribonucleoprotein L facilitates recruitment of 53BP1 and BRCA1 at the DNA break sites induced by oxaliplatin in colorectal cancer. Hu W; Lei L; Xie X; Huang L; Cui Q; Dang T; Liu GL; Li Y; Sun X; Zhou Z Cell Death Dis; 2019 Jul; 10(8):550. PubMed ID: 31320608 [TBL] [Abstract][Full Text] [Related]
11. Exosome-transmitted miR-128-3p increase chemosensitivity of oxaliplatin-resistant colorectal cancer. Liu T; Zhang X; Du L; Wang Y; Liu X; Tian H; Wang L; Li P; Zhao Y; Duan W; Xie Y; Sun Z; Wang C Mol Cancer; 2019 Mar; 18(1):43. PubMed ID: 30890168 [TBL] [Abstract][Full Text] [Related]
12. The cancer chemotherapeutic 5-fluorouracil is a potent Fusobacterium nucleatum inhibitor and its activity is modified by intratumoral microbiota. LaCourse KD; Zepeda-Rivera M; Kempchinsky AG; Baryiames A; Minot SS; Johnston CD; Bullman S Cell Rep; 2022 Nov; 41(7):111625. PubMed ID: 36384132 [TBL] [Abstract][Full Text] [Related]
13. Hsa_circ_0079662 induces the resistance mechanism of the chemotherapy drug oxaliplatin through the TNF-α pathway in human colon cancer. Lai M; Liu G; Li R; Bai H; Zhao J; Xiao P; Mei J J Cell Mol Med; 2020 May; 24(9):5021-5027. PubMed ID: 32243061 [TBL] [Abstract][Full Text] [Related]
14. Engineering lauric acid-based nanodrug delivery systems for restoring chemosensitivity and improving biocompatibility of 5-FU and OxPt against Su M; Wen X; Yu Y; Li N; Li X; Qu X; Elsabahy M; Gao H J Mater Chem B; 2024 Apr; 12(16):3947-3958. PubMed ID: 38586917 [TBL] [Abstract][Full Text] [Related]
15. Engineered exosomes for targeted co-delivery of miR-21 inhibitor and chemotherapeutics to reverse drug resistance in colon cancer. Liang G; Zhu Y; Ali DJ; Tian T; Xu H; Si K; Sun B; Chen B; Xiao Z J Nanobiotechnology; 2020 Jan; 18(1):10. PubMed ID: 31918721 [TBL] [Abstract][Full Text] [Related]
16. Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21. Yang Y; Weng W; Peng J; Hong L; Yang L; Toiyama Y; Gao R; Liu M; Yin M; Pan C; Li H; Guo B; Zhu Q; Wei Q; Moyer MP; Wang P; Cai S; Goel A; Qin H; Ma Y Gastroenterology; 2017 Mar; 152(4):851-866.e24. PubMed ID: 27876571 [TBL] [Abstract][Full Text] [Related]
18. Knockdown of circ_0004585 enhances the chemosensitivity of colorectal cancer cells to 5-fluorouracil via the miR-874-3p/CCND1 axis. Wang S; Cao J; Pei L Histol Histopathol; 2023 Jan; 38(1):99-112. PubMed ID: 35900059 [TBL] [Abstract][Full Text] [Related]
19. CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer. Hu JL; Wang W; Lan XL; Zeng ZC; Liang YS; Yan YR; Song FY; Wang FF; Zhu XH; Liao WJ; Liao WT; Ding YQ; Liang L Mol Cancer; 2019 May; 18(1):91. PubMed ID: 31064356 [TBL] [Abstract][Full Text] [Related]
20. Fusobacterium nucleatum-induced exosomal HOTTIP promotes gastric cancer progression through the microRNA-885-3p/EphB2 axis. Xin Y; Li X; Zhang M; Shang Z; Luo Z; Wang Y; Gui X; Liu Q; Li T; Zeng S; Schiöth HB; Zhang X; Zhang Y Cancer Sci; 2023 Jun; 114(6):2360-2374. PubMed ID: 36898846 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]